Skip to main content

Obesity

Feature content

Julian Hamilton-Shield

06-04-2022 | Children | View from the clinic | Article

Treatment priorities in children with type 2 diabetes

Julian Hamilton-Shield explains why weight loss is the key to type 2 diabetes management in children (2:04).

05-04-2022 | Ethnic groups | Feature | Article

Ethnicity and childhood type 2 diabetes: Causes and consequences

Why and how does ethnicity influence risk and management approach for pediatric type 2 diabetes? We talk to childhood obesity specialist Julian Hamilton-Shield.

05-04-2022 | Metabolic surgery | Feature | Article

Metabolic surgery for children: Finding the sweet spot

Torsten Olbers puts the case for metabolic surgery as a treatment option for children with type 2 diabetes.

Phil Zeitler

05-04-2022 | Children | View from the clinic | Article

Why type 2 diabetes is so challenging to manage in children

Phil Zeitler discusses the pathophysiology of type 2 diabetes in children, and why it is so resistant to conventional management (2:58). 

AG Unnikrishnan

05-04-2022 | Children | View from the clinic | Article

When to screen for type 2 diabetes in children

AG Unnikrishnan highlights the problem of underdiagnosis of type 2 diabetes in children, and explains who to prioritize for screening (2:14).

White plate with spoon and fork in clock formation, fasting concept

31-03-2022 | Diet | Hot topic review | Article

Fasting and people with diabetes

Read this Hot Topic Review to catch up on the latest research into the risks and benefits of fasting for people with diabetes.

09-07-2021 | COVID-19 | Ask the expert | Article

An update on COVID-19 and diabetes

Stefan Bornstein provides an overview of the current understanding about COVID-19 and diabetes, including medications, vaccines, and the impact of SARS-CoV-2 infection on diabetic ketoacidosis.

Domenica Rubino

23-03-2021 | Semaglutide | Commentary | Article

STEP 4: Long-term semaglutide treatment combats weight regain

Domenica Rubino discusses the chronicity of obesity, and how STEP 4 demonstrates the need for long-term semaglutide treatment to avoid weight regain (5:59).

Ildiko Lingvay

04-03-2021 | Semaglutide | Commentary | Article

STEP 2: A higher semaglutide dose in people with type 2 diabetes

Ildiko Lingvay discusses the STEP 2 findings, and why a higher semaglutide dose may be optimal for most people with type 2 diabetes (8:06).

Thomas Wadden

25-02-2021 | Semaglutide | Commentary | Article

STEP 3: Semaglutide plus intensive lifestyle therapy for weight loss

Thomas Wadden explains the rationale behind STEP 3 trial, and why semaglutide is the “breakthrough people with overweight and obesity have been waiting for.” (7:41)

Files

11-02-2021 | Semaglutide | At a glance | Article

A quick guide to the STEP trials

Read our round-up of the STEP phase 3 trials of semaglutide 2.4 mg in people with obesity, plus the SELECT cardiovascular outcomes trial.

John WIlding

11-02-2021 | Semaglutide | Commentary | Article

STEP 1: Semaglutide for weight loss

Lead author of the STEP 1 trial, John Wilding, discusses the findings and what they may mean for the treatment of people with obesity (5:42)

Files

14-10-2020 | Tirzepatide | At a glance | Article

A quick guide to the SURPASS and SURMOUNT trials

Read our overview of the SURPASS trials of the dual GLP-1/GIP receptor agonist tirzepatide in people with type 2 diabetes, plus the SURMOUNT trials in people with obesity.

Alison Barnes

29-07-2020 | Type 2 diabetes | Podcast | Article

The DiRECT approach to weight loss: Efficacious and pragmatic

DiRECT trial dietitian Alison Barnes discusses the challenges and triumphs of using a very-low-calorie, total-meal-replacement diet to help people with type 2 diabetes achieve weight loss and maintenance (25:34).

24-09-2019 | Type 2 diabetes | Podcast | Article

How was it for you? The experts discuss EASD 2019

Our clinical advisors discuss their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial.

Sleep apnea (symbolic image with model)

14-12-2018 | Sleep apnea | Editorial | Article

Diabetes and obstructive sleep apnea syndrome: Double trouble

Obstructive sleep apnea syndrome is a common and potentially serious comorbidity in people with diabetes and obesity. John Wilding highlights what you need to know about the condition.

Pink dumbbell, sweets and glucose meter

14-09-2018 | Diet | Patient and physician’s perspective | Article

Diabetes and diet: A patient and dietitian’s perspective

A patient with type 2 diabetes and a specialist dietitian discuss the patient’s experience and difficulties with controlling weight and strategies that can help a patient in this situation.

Mara Zemgaliete/stock.adobe.com

19-03-2018 | Diet | Podcast | Article

UK nutrition guidelines: A fresh approach

Board members John Wilding and Pamela Dyson talk about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines (9:43).

John Wilding

16-03-2018 | Obesity | Editorial | Article

The updated Diabetes UK nutrition guidelines: an obesity specialist’s view

John Wilding explains how the latest update of the nutrition guidelines will help clinicians working with patients with obesity (1:53).

Physical activity

03-01-2018 | Physical activity | Editorial | Article

Physical activity for health, weight loss, and diabetes prevention and treatment: What should be recommended?

Editorial Board member John Wilding highlights the current evidence for the benefits of physical activity across various domains of type 2 diabetes care and prevention, presenting his view of what should be recommended.